Discuss current guidance for the early identification/diagnosis and optimal management of MM Evaluate current/emerging single agent and combination treatment options for MM, including efficacy/safety data and considerations for optimal use Assess the role of PCPs and the multidisciplinary care team in the management of treatment-related adverse events in MM to improve patient outcomes
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-pupc-102-4
- Start Date: 2024-08-23 05:00:00
- End Date: 2024-08-23 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Dietetic CPEUs: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Astellas (Any division) - Amount: 0 - Is Kind Support: False Source: GlaxoSmithKline - Amount: 0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest